Cargando…

Mast cells and the liver aging process

It has now ascertained that the clinical manifestations of liver disease in the elderly population reflect both the cumulative effects of longevity on the liver and the generalized senescence of the organism ability to adjust to metabolic, infectious, and immunologic insults. Although liver tests ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Grizzi, Fabio, Di Caro, Giuseppe, Laghi, Luigi, Hermonat, Paul, Mazzola, Paolo, Nguyen, Diane D, Radhi, Saba, Figueroa, Jose A, Cobos, Everardo, Annoni, Giorgio, Chiriva-Internati, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599827/
https://www.ncbi.nlm.nih.gov/pubmed/23496863
http://dx.doi.org/10.1186/1742-4933-10-9
Descripción
Sumario:It has now ascertained that the clinical manifestations of liver disease in the elderly population reflect both the cumulative effects of longevity on the liver and the generalized senescence of the organism ability to adjust to metabolic, infectious, and immunologic insults. Although liver tests are not significantly affected by age, the presentation of liver diseases such as viral hepatitis may be subtler in the elderly population than that of younger patients. Human immunosenescence is a situation in which the immune system, particularly T lymphocyte function, deteriorates with age, while innate immunity is negligibly affected and in some cases almost up-regulated. We here briefly review the relationships between the liver aging process and mast cells, the key effectors in a more complex range of innate immune responses than originally though.